Skip to main content
Premium Trial:

Request an Annual Quote

Cancer Genetics, Agilent Sign FISH Probe Supply Deal

NEW YORK (GenomeWeb) — Cancer Genetics said this week that it has signed a non-exclusive supply agreement with Agilent Technologies for probe reagents for its FISH-based HPV-Associated Cancer Test (FHACT).

CGI's test — a laboratory developed assay under CLIA in the US that also has CE marking — assesses genomic changes often found in cervical cancers to help identify patients who are at higher risk for disease progression.

Under the terms of the deal, Agilent will manufacture custom probes for CGI for use in the test. Rutherford, New Jersey-based CGI said it also intends to outlicense the probes through domestic and international distribution channels, with licensors able to purchase Agilent-manufactured probes.

Additional terms were not disclosed.

"This agreement marks an important milestone for Cancer Genetics and the company's FHACT test as it allows for expansion of our international business opportunities by outlicensing our probes, which is an integral part of the company's new strategy for revenue generation and path to profitability," CGI CEO John Roberts said in a statement.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.